6 NJ Kids Hospitalized With Dangerous Inflammatory Syndrome, Highest in One Day
New Jersey has reported a single-day record number of a dangerous multisystem inflammatory syndrome called MIS-C in children, the state’s health commissioner said Monday. Of the six new cases reported on Friday, all of the children are currently hospitalized, according to Health Commissioner Judy Persichilli who warned parents that COVID-19 cases aren’t always mild in children and urged everyone...
NJ Health Commissioner: 4 New COVID Pediatric Deaths Had No Underlying Conditions
Health Commissioner Judith Persichilli said that there have been four pediatric deaths, including three infants, associated with the coronavirus in the state since Christmas.
Pfizer Vaccine Highly Effective at Stopping MIS-C in Kids, New Study Finds
Pfizer’s COVID-19 vaccine was 91% effective at preventing kids from developing the rare but serious COVID complication known as MIS-C, according to a new study released Friday. Multisystem inflammatory syndrome in children, or MIS-C, is a severe condition usually seen two weeks or more after an otherwise mild COVID infection in kids. The study of 283 kids at 24 hospitals…
NJ Reports Uptick of Rare COVID-Related Illness in Children Since Last Week
New Jersey has experienced the biggest weekly uptick in cases concerning multisystem inflammatory syndrome in children (MIS-C) in quite some time, according to state officials. On Monday, the state’s Commissioner of Health Judith Persichilli revealed there are five new reports of MIS-C since Gov. Phil Murphy’s previous press conference held last week. According to Persichilli there are 141 cumulative cases in...
White House on Approval for Children's Coronavirus Shots: ‘It's a Landmark Moment'
Members of the White House Coronavirus Task Force spoke optimistically the day after the Pfizer vaccine earned CDC approval for children ages 5 to 11, highlighting the vaccine’s safety and efficacy and encouraging parents to get their children vaccinated.
FDA Authorizes Pfizer Vaccine for Kids 5-11
The FDA announced Friday that it had authorized emergency use of the Pfizer coronavirus vaccine for children ages 5-11.